MMWR Morb Mortal Wkly Rep. 2006 Aug 25;55(33):916-8.
In May 1999, the World Health Assembly reaffirmed the commitment of the World Health Organization (WHO) to eradicate poliomyelitis and urged all member states to begin the process leading to the laboratory containment of wild poliovirus (WPV). The WHO global action plan for laboratory containment of WPV begins with a survey of all biomedical facilities (Phase I). The purpose of the survey is to alert institutions and facilities to the need for containment, encourage reduction of WPV materials, and develop a national inventory of facilities holding such materials. The objective of Phase I is to provide a facility database for use in all subsequent steps toward global poliovirus containment. This report describes completion of Phase I containment by the European Region, the first of the six WHO regions to accomplish this goal.
1999年5月,世界卫生大会重申世界卫生组织(世卫组织)根除脊髓灰质炎的承诺,并敦促所有成员国启动对野生脊髓灰质炎病毒(WPV)进行实验室封存的进程。世卫组织关于WPV实验室封存的全球行动计划始于对所有生物医学设施的调查(第一阶段)。该调查的目的是提醒各机构和设施注意封存的必要性,鼓励减少WPV材料,并编制持有此类材料的设施的国家清单。第一阶段的目标是提供一个设施数据库,供后续全球脊髓灰质炎病毒封存的所有步骤使用。本报告描述了欧洲区域完成第一阶段封存的情况,欧洲区域是世卫组织六个区域中第一个实现这一目标的区域。